Published in J Immunol on July 01, 1975
Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A. J Clin Invest (1979) 1.34
Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome. Clin Exp Immunol (1981) 1.32
Monomeric (7S) IgM in chronic liver disease. Clin Exp Immunol (1979) 0.95
Low molecular weight (7S) IgM and free light chains in the sera of patients with the tropical splenomegaly syndrome. Clin Exp Immunol (1977) 0.83
A monoclonal macroglobulin with antinuclear activity. J Clin Pathol (1979) 0.80
Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy. Clin Exp Immunol (1979) 0.79
Monomeric (7S) IgM found in the serum of rheumatoid arthritis patients share idiotypes with pentameric (19S) monoclonal rheumatoid factors. J Clin Invest (1987) 0.79
Seronegative rheumatoid arthritis, rheumatoid factor cross reactive idiotype expression, and hidden rheumatoid factors. Ann Rheum Dis (1989) 0.75
Low molecular weight IgM in sera of children following bone marrow transplantation for severe aplastic anaemia and acute leukaemia. Clin Exp Immunol (1983) 0.75
Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer. Clin Immunol (2015) 0.75
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science (1986) 12.49
Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol (1985) 7.35
A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature (1988) 6.39
Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3' ends. Cell (1980) 5.59
Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol (1986) 5.31
The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) (1971) 4.65
Association between polyarteritis and Australia antigen. Lancet (1970) 4.32
Financial cost of social exclusion: follow up study of antisocial children into adulthood. BMJ (2001) 4.15
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol (1988) 4.13
In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol (1986) 4.12
Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol (2001) 4.03
Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J Immunol Methods (1985) 3.91
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76
Identification of the residues in human CD4 critical for the binding of HIV. Cell (1989) 3.71
Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. J Infect Dis (1985) 3.42
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Alternative strategies for stroke care: a prospective randomised controlled trial. Lancet (2000) 3.27
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med (1990) 3.01
HIV infection does not require endocytosis of its receptor, CD4. Cell (1988) 2.88
Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates. AIDS Res Hum Retroviruses (1995) 2.70
A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess (2001) 2.46
Experimental chronic glomerulitis. J Exp Med (1968) 2.44
Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis. J Clin Invest (1970) 2.41
The impact on general practitioners of the changing balance of care for elderly people living in institutions. BMJ (1998) 2.31
Clinical and microbial features of prosthetic joint infection. Am J Med (1984) 2.31
Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen. Nat Genet (1994) 2.30
Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity. Proc Natl Acad Sci U S A (1987) 2.23
Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor. J Clin Invest (1985) 2.21
Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy (2004) 2.20
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet (1986) 2.11
Studies of cryoproteins in systemic lupus erythematosus. J Clin Invest (1967) 2.09
Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. J Clin Invest (1984) 2.07
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry (2000) 2.01
Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med (1975) 2.00
Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore) (1976) 1.98
Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol (2008) 1.97
Myxovirus antibody increases in human connective tissue disease. Science (1970) 1.94
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess (2005) 1.83
Character of non-precipitating antibodies. Immunology (1970) 1.79
Immune-complex disease. N Engl J Med (1969) 1.73
The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med (1985) 1.71
Infection of chimpanzees with lymphadenopathy-associated virus. Lancet (1984) 1.67
Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma (1984) 1.67
Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature (1993) 1.63
Working from upstream to improve health care: the IHI interdisciplinary professional education collaborative. Jt Comm J Qual Improv (1996) 1.61
Home treatment for mental health problems: a systematic review. Health Technol Assess (2001) 1.57
Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol (1971) 1.56
The release of DNA into serum and synovial fluid. Arthritis Rheum (1971) 1.56
Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Ann Intern Med (1985) 1.53
Comparison of T and B cell analyses on fresh and aged blood. J Immunol Methods (1984) 1.53
Necrotizing vasculitis after acute serous otitis media. Ann Intern Med (1974) 1.52
Development of a new measure of health-related quality of life for people with dementia: DEMQOL. Psychol Med (2006) 1.50
Generation of T helper cells in vitro. IV. F1 T helper cells primed with antigen-pulsed parental macrophages are genetically restricted in their antigen-specific helper activity. J Immunol (1978) 1.48
Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet (1994) 1.48
Aortic insufficiency in systemic lupus erythematosus. Arthritis Rheum (1969) 1.46
Home treatment for mental health problems: a systematic review. Psychol Med (2002) 1.44
Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses (2001) 1.44
The economic impact of autism in Britain. Autism (2001) 1.43
Sporadic focal dystonia in northwest Germany: molecular basis on chromosome 18p. Ann Neurol (1997) 1.43
Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. J Immunol (1989) 1.42
Decreased C'-1q protein concentration and agglutinating activity in agammaglobulinaemia syndromes: an inborn error reflected in the complement system. Clin Exp Immunol (1968) 1.41
Community psychiatric nurse teams: cost-effectiveness of intensive support versus generic care. Br J Psychiatry (1994) 1.41
Vasculitis in association with Australia antigen. J Exp Med (1971) 1.40
Feedback suppression: phenotypes of T cell subsets involved in the Ly1 T cell-induced immunoregulatory circuit. J Immunol (1980) 1.39
'Hot pulp' syndrome. Aust Dent J (1992) 1.39
Vasculitis syndromes: clinical and experimental models. Am J Med (1976) 1.39
Clinical studies of hemolytic complement and the 11S component. Am J Med (1967) 1.39
Same-day transfer of patients to the cardiac telemetry unit after surgery: the Rapid after Bypass Back into Telemetry (RABBIT) program. Crit Care Nurse (2000) 1.38
Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychol Med (2003) 1.35
Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A. J Clin Invest (1979) 1.34
Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet (2005) 1.33
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
The 0.78 A structure of a serine protease: Bacillus lentus subtilisin. Biochemistry (1998) 1.32
The transmission/disequilibrium test and parental-genotype reconstruction for X-chromosomal markers. Am J Hum Genet (2000) 1.32
HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. JAMA (1986) 1.31
Properties of soluble immune complexes. J Immunol (1970) 1.31
Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann Intern Med (1982) 1.31
Rheumatoid meningitis: a localized immune process. Ann Intern Med (1979) 1.30
Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia. J Neurol Neurosurg Psychiatry (2006) 1.28
Generation of T helper cells in vitro. V. Antigen-specific Ly1+ T cells mediate the helper effect and induce feedback suppression. J Immunol (1979) 1.24
Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding. Int J Geriatr Psychiatry (2001) 1.24
Organization of the amygdalopetal projections from modality-specific cortical association areas in the monkey. J Comp Neurol (1980) 1.24
Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study. Br J Psychiatry (1998) 1.24
A gene for universal congenital alopecia maps to chromosome 8p21-22. Am J Hum Genet (1998) 1.23
Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr (1988) 1.22
International differences in home treatment for mental health problems. Results of a systematic review. Br J Psychiatry (2002) 1.22
Mapping of the gene for X-chromosomal split-hand/split-foot anomaly to Xq26-q26.1. Hum Genet (1993) 1.21
Virus antibodies in systemic lupus erythematosus and other connective tissue diseases. Ann Rheum Dis (1973) 1.21
Serum protein binding of thyroxine and diphenylhydantoin. J Clin Endocrinol Metab (1966) 1.20
Cost-effectiveness evaluation of compliance therapy for people with psychosis. Br J Psychiatry (1998) 1.20
Penetration of CD4 T cells by HIV-1. The CD4 receptor does not internalize with HIV, and CD4-related signal transduction events are not required for entry. J Immunol (1991) 1.20
Developmental and communicative interrelations of Ly123 and Ly1 cell sets. J Exp Med (1980) 1.19
Large linkage analysis in 100 families with autosomal recessive spinal muscular atrophy (SMA) and 11 CEPH families using 15 polymorphic loci in the region 5q11.2-q13.3. Genomics (1994) 1.18